Tower Research Capital (TRC)’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111K Sell
4,943
-21,925
-82% -$572K ﹤0.01% 2113
2026
Q1
$735K Buy
26,868
+25,194
+1,505% +$894K 0.02% 679
2025
Q4
$69.6K Sell
1,674
-938
-36% -$38.1K ﹤0.01% 2197
2025
Q3
$121K Buy
2,612
+1,167
+81% +$62.3K ﹤0.01% 1851
2025
Q2
$76.4K Sell
1,445
-781
-35% -$41.3K ﹤0.01% 2609
2025
Q1
$124K Sell
2,226
-1,015
-31% -$48.6K ﹤0.01% 1654
2024
Q4
$140K Buy
3,241
+580
+22% +$25.8K ﹤0.01% 1947
2024
Q3
$136K Buy
2,661
+568
+27% +$38K ﹤0.01% 1978
2024
Q2
$132K Sell
2,093
-2,003
-49% -$120K ﹤0.01% 2381
2024
Q1
$271K Sell
4,096
-2,944
-42% -$239K 0.01% 1220
2023
Q4
$691K Buy
7,040
+2,711
+63% +$236K 0.01% 1120
2023
Q3
$347K Buy
4,329
+1,713
+65% +$134K 0.01% 1090
2023
Q2
$211K Sell
2,616
-366
-12% -$34.2K 0.01% 1525
2023
Q1
$362K Sell
2,982
-3,194
-52% -$434K 0.01% 1024
2022
Q4
$823K Sell
6,176
-924
-13% -$112K 0.03% 459
2022
Q3
$792K Buy
7,100
+3,570
+101% +$457K 0.01% 814
2022
Q2
$479K Sell
3,530
-203
-5% -$30.5K 0.01% 1162
2022
Q1
$622K Buy
3,733
+779
+26% +$148K 0.01% 1025
2021
Q4
$528K Buy
2,954
+991
+50% +$177K 0.01% 1077
2021
Q3
$348K Sell
1,963
-1,086
-36% -$180K 0.01% 1261
2021
Q2
$490K Sell
3,049
-1,783
-37% -$274K 0.01% 1205
2021
Q1
$723K Sell
4,832
-5,471
-53% -$663K 0.01% 950
2020
Q4
$1.02M Buy
+10,303
New +$1.03M 0.03% 515

Other funds holding CNXC

Tower Research Capital (TRC)'s CNXC Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Concentrix (CNXC) stake by 82% in Q2 2026, selling an estimated $572K and leaving 4,943 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #2113.

Tower Research Capital (TRC) first reported a position in CNXC in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.02M in Q4 2020. 272 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Tower Research Capital (TRC) held 4,943 shares of Concentrix worth $111K as of Q2 2026.
  • Tower Research Capital (TRC) sold 21,925 Concentrix shares in Q2 2026, an estimated $572K.
  • Concentrix made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2113 holding.
  • Tower Research Capital (TRC) first reported a position in Concentrix in Q4 2020 and has held it in 23 quarters since.
  • Tower Research Capital (TRC)'s Concentrix position peaked at $1.02M in Q4 2020.
  • 272 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.